Akums Drugs and Pharmaceuticals informs about analyst meet

Akums Drugs & Pharmaceuticals Ltd. | Pharmaceuticals & Drugs | Healthcare | BSE: 544222 | NSE: AKUMS

03 Feb 2025 Evaluate

Akums Drugs and Pharmaceuticals has informed that pursuant to regulation 30 read with Part A of Schedule III of SEBI (Listing Obligation and Disclosure Requirements) Regulations, 2015, Akums Drugs & Pharmaceuticals will be hosting earnings/ analysts conference call (group meet) on Friday, February 7, 2025 at 16:00 PM IST for un-audited financial results of Q3 FY25. Dial-in details are enclosed. A copy of this disclosure is being updated on website of the Company at www.akums.in.

The above information is a part of company’s filings submitted to BSE.

Peers

Company Name	CMP
Sun Pharma. Inds.	1845.40
Dr. Reddys Labs.	1219.20
Cipla	1386.20
Lupin	2058.40
Zydus Lifesciences	1209.10
View more..

Name of the IA registered with SEBI:	The Alchemists Ark Pvt. Ltd.
Logo:
Trade/Brand Name of IA:	MoneyWorks4Me Investment Advisers
Brand Logo:
SEBI Registration Number:	INA000013323 Validity – May 16, 2019 – Perpetual
Registration:	Non-Individual
BSE Enlistment No:	1187
Address:	B-101, Signet Corner Building, Balewadi Phata, Baner, Pune, Maharashtra 411045

Compliance Officer Details:	Name: Shrikant Jagtap Email: shrikant.jagtap@moneyworks4me.com	Telephone: +919860359463 Address: Same as IA
Grievance Officer Details:	Name: Mukta Vaze Email: mukta.vaze@moneyworks4me.com	Telephone: +919860919463 Address: Same as IA
Principal Officer Details:	Name: Atharva Bhide Email: atharva.bhide@moneyworks4me.com	Telephone: +919175899463 Address: Same as IA
Standard Warning:	Investment in securities market are subject to market risks. Read all the related documents carefully before investing.
Disclaimer:	Registration granted by SEBI, enlistment with exchange and certification from NISM in no way guarantee performance of the intermediary or provide any assurance of returns to investors.